Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
Clinical trial NCT06794229 · RECRUITING
Trial details
- NCT number
- NCT06794229
- Sponsor
- Qian Qin
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-30
- Primary completion
- 2028-06-06
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.